Nasdaq biol.

BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99.BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced the FDA 510(k) clearance of the Ed gePRO system for endodontists seeking a more effective cleaning and disinfection alternative within root canal procedures. The new laser …These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...Nov 27, 2023 · Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener FOOTHILL RANCH, Calif., Jan. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary ...

BIOLASE, Inc. (NASDAQ:BIOL) fell 43.3% to $1.85 in pre-market trading after the company announced pricing of $4.5 million underwritten public offering of Series J convertible redeemable preferred ...Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ...

BIOLASE (NASDAQ:BIOL) plummets 47.31% premarket on pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 ...Aug 10, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -...

LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a ...FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78 ...FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth ...

Nov 29, 2023 · What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00.

Nov 5, 2023 · Posted by Defense World Staff on Nov 5th, 2023. BIOLASE ( NASDAQ:BIOL – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a ...

The 36-month beta value for BIOL is also noteworthy at 1.33. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for BIOL is $16.33, which is $14.66 above than the current price.IRVINE, Calif., April 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a leader in medical devices, today announced that it expects to join the fight against the coronavirus (COVID-19 ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the ...BIOL’s shares have dropped by -21.84% in the last five days, while they have subtracted -8.67% in the last month. Further, it is currently trading at a price-to-book ratio of 1.12. LORD JONATHAN T MD, Director, of BIOLASE Inc. (BIOL), sold 11,038 BIOLASE Inc. stock in an exchange on Dec 15.Aug 10, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -... Oct 20, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No ...

LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, …The stock was up 8.89% to $3.43 in after-hours trading. Agios Reports Positive Phase 3 Data For Mitapivat In Treating Genetic Blood Disorder. Agios Pharmaceuticals Inc (NASDAQ:AGIO) said that the ...Jul 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ... Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ: BIOL).In a recent filing with the Securities and Exchange Commission, Mr. Feinberg disclosed ...On March 9th, the NASDAQ rallied up by around 4% during intraday trading. These gains were led by tech, as a large rebound occurred following a market correction over the past few weeks. Shares of ... BIOL shares climbed slightly on the announcement that the European Patent Office may give a specification to its Dual Pulse-Width Medical …

FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...Biolase (BIOL) preço da ação, gráfico, book, notícias; O fórum mais popular do Brasil. Rankings, ferramentas, índices e muito mais. De Graça!

BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share for the quarter, topping analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter. BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99.IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a ...Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that Institutional Shareholder Services (“ISS”) recommends that …BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023. BIOLASE, Inc.(NASDAQ: BIOL), the global ...morningstar.com - November 1 at 12:25 PM. BIOLASE, Inc. (BIOL) ca.finance.yahoo.com - October 18 at 8:14 AM. BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. finance.yahoo.com - September 18 at 5:11 PM.BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023. BIOLASE, Inc.(NASDAQ: BIOL), the global ...

The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ...

NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.

Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...Feb 10, 2021 · FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ... Nov 8, 2023 · BIOL) stock’s latest price update. The stock price of Biolase Inc (NASDAQ: BIOL) has jumped by 6.01 compared to previous close of 1.58. Despite this, the company has seen a fall of -0.30% in its stock price over the last five trading days. FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ: BIOL).In a recent filing with the Securities and Exchange Commission, Mr. Feinberg disclosed ...The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE StockholdersOf the funds tracked by Insider Monkey, Hal Mintz’s Sabby Capital has the biggest position in Biolase Inc (NASDAQ:BIOL), worth close to $0.1 million, comprising less than 0.1%% of its total 13F ...Nov 29, 2023 · What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...IRVINE, Calif., Nov. 26, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the following two investor ...IRVINE, Calif., Nov. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has launched the Epic Hygiene Academy, bringing together ...

BIOLASE, Inc. (NASDAQ:BIOL) fell 10% to $1.35 in pre-market trading. Biolase shares jumped 44% on Tuesday after the company announced Q4 preliminary sales guidance above analyst estimates..The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.8 Nov 2023 ... Biolase (NASDAQ:BIOL) shares are rising more than 24% with the release of positive study results. Upwork (NASDAQ:UPWK) stock is heading over ...Instagram:https://instagram. microsoft target priceeog tickerwho owns hundaismall caps On Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge into U.S. public markets. Korro's stock price soared …BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ... fidelity select energy portfoliojob hunting in india BIOLASE, Inc. (BIOL). NASDAQ: BIOL · IEX Real-Time Price · USD. cruise automation stock Zomedica (NYSEMKT:ZOM), Tonix Pharmaceuticals (NASDAQ:TNXP), and Biolase (NASDAQ:BIOL) all were on a roller-coaster ride over the past few days. Except for online chatter, these penny stocks in .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its third quarter ended September...